Cooperative Agreement 2134020
Award Date 3/1/22
Completion Date 2/29/24
Dollars Obligated $999K
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
New Orleans, LA 70118, USA
Similar Awards
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award supports the development of a novel device that can rapidly and automatically extract pathogen DNA from whole blood samples to enable faster diagnosis of sepsis. The $274,858 award to New England Hemolytics, Inc., with a project period from September 1, 2024 to February 28, 2025, will fund the testing and optimization of this technology across common sepsis-causing pathogens. The...
- Hermes Life Sciences LTD received a $1,126,590 cooperative agreement award from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to support the SBIR PHASE II: BLOOD-PLASMA SEPARATION FOR POINT-OF-CARE DIAGNOSTIC TESTING project. The funding period is from August 1, 2021 through January 31, 2024. Under this cooperative agreement, Hermes Life Sciences LTD will develop technologies for blood-plasma separation to enable point-of-care...
- This CAREER grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) is awarded to Lehigh University for the development of a compact digital biosensing system enabled by localized acoustic streaming. The $332,826 project aims to create an integrated solution for performing high-performance, portable diagnostic testing at the point-of-care setting. The new testing platform leverages vibrating capillaries and 3D-printed microdevices to achieve high detection...
- This Cooperative Agreement award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) provides $1,144,758.00 to Promedix, Inc. to develop an automated electronic measurement device for improving the diagnosis and treatment of sepsis. The project aims to create a novel system that can rapidly and quantifiably assess capillary refill time, a key indicator of sepsis, in order to enable earlier intervention and improve patient outcomes. This Phase...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Leap Photonics Inc. is focused on developing an acousto-optic beam steering (AOBS) technology for LIDAR systems. The key objectives are to create a compact, solid-state, and cost-effective AOBS chip that can be seamlessly integrated with existing LIDAR platforms, while enhancing beam steering precision and near-infrared integration for time-of-flight LIDAR. The...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Macula Vision Systems Inc., a for-profit organization, supports the development of a novel microscopy platform to automate the interpretation of microbiology lab tests performed in hospitals. The project aims to address the shortage of trained lab technicians by engineering a specialized light source, customized camera, and AI-enabled algorithms to analyze...
- The National Science Foundation awarded a $255,957 STTR Phase I Project Grant to CHS Healthcare Ventures Inc., doing business as Lightengale, to develop a lighted infusion line to optimize care and decrease complications for critically ill patients in infectious isolation situations such as COVID-19. The grant is funded through the NSF's Technology, Innovation, and Partnerships program (CFDA 47.084) and aims to advance science and engineering research leading to breakthrough technologies and...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $984,381 to Cobio Diagnostics Inc. in Aurora, Colorado aims to expand a diagnostic tool that enables rapid, direct-from-specimen identification and antimicrobial susceptibility testing of major bloodborne bacterial pathogens. The project will develop a regulatory pathway for FDA clearance, characterize antibodies to expand the test, and validate the expanded tests...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award for $997,142 aims to develop a rapid phenylalanine blood level monitor for patients with phenylketonuria (PKU), a lifelong genetic disorder. The product consists of a test strip and device that can provide frequent, accessible monitoring of phenylalanine levels from a finger prick to improve disease management and patient outcomes. The project focuses on optimizing the...
- This $997,693 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an interactive health assessment and monitoring platform to improve patient-provider communication and reduce healthcare costs. The project by Literaseed, Inc. integrates electronic health record (EHR) data with natural language processing (NLP) techniques to extract valuable information from medical records, enabling...